study. Unfortunately, the report they cite was published after our review was completed. In a similar vein, given the dearth of studies of OXC in subtypes of mania, publication of Mazza et al's data regarding the efficacy of OXC in severe and psychotic mania would be a valuable addition to the literature.
It is an unfortunate consequence of the current pharmacoeconomic climate-and the limited remaining duration of patent protection for OXC-that adequately powered clinical trials to definitively assess its safety and efficacy are unlikely to be carried out. We feel that patients with BD refractory to standard therapies will benefit from the availability of other treatment options. In this light, we believe that our clinical recommendations are appropriately cautious and justified by the available data:
We recommend using OXC as monotherapy or as add-on therapy in refractory mania, but recommend it be used predominantly as an add-on treatment for other phases of BPD in patients who have not. improved using well-established treatments or in patients who have difficulty tolerating adequate dosages. 1, p 540 Wetid Pratoomsri MD David Bond, MD Lakshmi Yatham, MBBS Vancouver, Canada
Re: Community Treatment Orders for Psychiatric Patients: The Emperor With No Clothes

Dear Editor:
We appreciated reading the spirited debate between Dr O'Reilly, on the one hand, and Dr Kisely and Ms Campbell, on the other, about community treatment orders (CTOs) [1] [2] [3] [4] and were pleased to see that the results of our North Carolina study 5 continue to animate discussion of this important and controversial topic. Clearly, the use of legal leverage in community-based mental health treatment poses challenging questions for research and policy; it is hardly surprising that experts disagree, in good faith, about both the intervention and the evidence for its effectiveness.
Several points underlying Kisely and Campbell's critique of our study in North Carolina warrant further comment.
First, Kisely and Campbell write,
The 1-year follow-up is therefore of a highly selected and potentially unrepresentative population that was not dangerous and was sufficiently compliant to participate in baseline and follow-up assessments. 1, p 684 The attrition problem that these authors highlight (18% in our study) was substantial but irrelevant to the hospital outcome data. We included admissions data for all study participants-even dropouts-in the "intent-to-treat" analysis of hospital recidivism.
Kisely and Campbell's suggestion that our study excluded all patients who were dangerous requires a qualifier. The exclusion criterion applied to patients with a documented recent history of serious violent behaviour involving weapon use or causing physical injury. However, one-third of randomized participants had engaged in acts of simple battery, or had been involved in physical fights, during the 4 months preceding enrolment. An additional 20% had made verbal threats of harm to others. Suicidality was also not an exclusion criterion. We think our study generalizes to a broader clinical population than one might imagine from reading Kisely and Campbell's critique.
Second, these authors write that the study failed to show "significant differences between intervention and control groups in terms of hospital or other outcomes . . . over the following 12 months." 1 In fact, using repeated-measures analysis, we found that "assignment to the outpatient commitment group was associated with a significantly lower odds of any readmission (odds ratio 0.64; 95% confidence interval, 0.46 to 0.88; P < 0.01)." 5, p 1972 This result was obtained from an intent-to-treat, monthly time-series analysis using the original randomized groups.
As Kisely and Campbell correctly observe, our analysis also revealed that the apparent effect of the intervention was concentrated heavily among participants who received extended court-ordered treatment. Still, the result was sufficiently strong to achieve statistical significance for the experimental group as a whole.
Finally, Kisely and Campbell state, Analysis of subjects who have not been randomly assigned to CTO groups of less or more than 180 days may reflect a bias where a CTO was selectively extended when it seemed to be helping the patient. 1, p 684 Our evidence suggests the opposite was true. Participating mental health centres agreed in advance to systematically review each expiring court order and file a petition to renew if the patient continued to meet legal criteria for outpatient commitment. Consequently, patients with a history of
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In the end, some will be persuaded by these results and others will not. As researchers, we take no advocacy position with respect to the policy of CTOs. Our goal has been to help build a base of evidence to inform the policy debate. Clearly, however, this is an area that warrants careful reflection as well as further research in different populations and jurisdictions.
Jeffrey Swanson, PhD Marvin Swartz, MD Durham, North Carolina
Reply: Community Treatment Orders for Psychiatric Patients: The Emperor With No Clothes
Dear Editor:
Drs Swanson and Swartz raise more questions than answers about their study. We will deal with these in turn. On the issue of attrition, we clearly stated that, of those who were randomized, there was an 82% completion rate in the North Carolina study. However, this does not take into account attrition prior to randomization. Of all eligible subjects, only 57% completed the North Carolina study.
They also say that the randomized controlled trial (RCT) samples were more typical than we suggest because only subjects with a documented recent history of violent behaviour involving weapons or causing physical injury were excluded, as opposed to less serious violence or verbal threats of harm. But what does that mean? Were the police involved? Were the patients arrested, charged, or convicted? These are crucial distinctions-our study of community treatment orders (CTOs) showed that it was only the presence of a conviction for injury against others that predicted the use of CTOs. 1 It is not unreasonable to suggest that patients convicted of assault may more closely resemble those excluded from the North Carolina study than those who made verbal threats or were involved in physical fights, who might or might not have been arrested or convicted. Moreover, this discussion does not apply to the New York study, where any history of violence led to exclusion. 2 Our commentary on the New York and North Carolina studies is based on the metaanalyses of our Cochrane Review. 3 There was no statistical difference on either fixedor random-effects models between patients randomly assigned to intervention or control groups. Post hoc subanalyses of patients nonrandomly allocated to longer orders are inevitably subject to selection bias. We suggest that this might have led to cases with a good prognosis being differentially selected; Swanson and Swartz suggest the opposite. The only way of elucidating this is to repeat the study with random allocation to 3 groups: control subjects, orders of less than 180 days, and orders of greater than 180 days.
They also say that, when using repeated-measures analysis, they found the outpatient commitment group had a significantly lower chance of readmission with an intent-to-treat, monthly time-series analysis using the original randomized groups. 4 Their paper actually states, Although the overall group assignment (outpatient commitment or control) was significant in this model, as demonstrated in Table 2 , this effect was dependent on increasing days of outpatient commitment. 4 Further, the reader is referred to a table ( Table 2 in their paper) where they present analyses of the effect of being on outpatient commitment for more than 180 days. What exactly does this mean? Is the effect in their logistic regression dependant or not dependant on days of outpatient commitment? Is it only apparent after 180 days? We can only rely on the information as given in their paper. However, this does seem a strange method of presenting the results of an RCT, which is not consistent with the methodology of the Cochrane Collaboration. It also seems merely another way of saying that only nonrandom allocation to orders of longer duration leads to reduced admission.
